長聖國際生技股份有限公司

長聖以創新再生醫療新藥研發為核心，專注於幹細胞與癌症免疫治療。
透過具國際專利的技術平台與臨床導向研發，開發安全、具療效潛力且可量產的再生醫療新藥，推動精準醫療走向國際。
Ever Supreme is focused on the development of innovative regenerative medicine drugs, with core expertise in stem cell and cancer immunotherapy.
Leveraging internationally patented technology platforms and a clinically driven development approach, we develop safe, scalable regenerative medicine drug candidates with strong therapeutic potential, advancing precision medicine to global markets.